Click image to view original image
| Bremelanotide PT-141 Systematic (IUPAC) name (3S,6S,9R,12S,15S,23S)-15-[(N-acetyl-L-norleucyl)amino]-9-benzyl-6-{3-[(diaminomethylidene)amino]propyl}-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaa zacyclotricosane-23-carboxylic acid Clinical data Legal status Unscheduled (US) Pharmacokinetic data Half-life 120 minutes[1] Identifiers CAS number 189691-06-3 Chemical data Formula C50H68N14O10 Mol. mass 1025.2 g/mol PT-141 Side Effects Despite promising results and excellent safety profile, the PT-141 Nasal Spray formulation was denied regulatory approval by the FDA due to concerns Package 10vials/pack; 12vials/pack; 5vials/pack 10mg/vial; 5mg/vial We can pack according to your requests |
